(2) *BRISTOL'S OPDIVO FAILS TO IMPROVE PFS IN FIRST-LINE NSCLC STUDY

*BRISTOL'S OPDIVO FAILS TO IMPROVE PFS IN FIRST-LINE NSCLC STUDY

Alerts: HALISTER, HALISTER1
Source: BN (Bloomberg News)

Tickers
BMY US (Bristol-Myers Squibb Co)
4528 JP (Ono Pharmaceutical Co Ltd)
MRK US (Merck & Co Inc)

To de-activate the "HALISTER" alert, click here
To modify this alert, click here

To de-activate the "HALISTER1" alert, click here
To modify this alert, click here

UUID: 7947283